Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R H Reitz

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Toxicology|October 28, 1996
Using PBPK modeling and comprehensive realism methodology for the quantitative cancer risk assessment of butadieneR L Sielken, R H Reitz, S M Hays
Basic Life Sciences|January 1, 1986
The role of pharmacokinetics in risk assessmentR H Reitz, T R Fox, P G Watanabe
Journal De Toxicologie Clinique Et Experimentale|January 1, 1988
Mechanistic considerations in carcinogenic risk estimationP G Watanabe, R H Reitz, A M Schumann
Advances in Experimental Medicine and Biology|January 1, 1981
Translation of pharmacokinetic/biochemical data into risk assessmentF K Dietz, R H Reitz, P G Watanabe, et al.
Food and Cosmetics Toxicology|October 1, 1981
Genetic and nongenetic events in neoplasiaW T Stott, R H Reitz, A M Schumann, et al.
Science (New York, N.Y.)|September 21, 1979
Chemical carcinogens: estimating the riskR H Reitz, J F Quast, P G Watanabe, et al.
Toxicology Letters|October 1, 1988
Pharmacokinetics, biochemical mechanism and mutation accumulation: a comprehensive model of chemical carcinogenesisR B Conolly, R H Reitz, H J Clewell, et al.
Basic Life Sciences|January 1, 1982
Genetic vs. nongenetic chemical carcinogenesis and risk assessmentR H Reitz, A M Schumann, P G Watanabe, et al.
Toxicology and Applied Pharmacology|February 1, 1996
In vivo and in vitro studies of perchloroethylene metabolism for physiologically based pharmacokinetic modeling in rats, mice, and humansR H Reitz, M L Gargas, A L Mendrala, et al.
Toxicology Letters|October 1, 1988
Incorporation of in vitro enzyme data into the physiologically-based pharmacokinetic (PB-PK) model for methylene chloride: implications for risk assessmentR H Reitz, A L Mendrala, C N Park, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Toxicology|October 28, 1996
Using PBPK modeling and comprehensive realism methodology for the quantitative cancer risk assessment of butadieneR L Sielken, R H Reitz, S M Hays
Basic Life Sciences|January 1, 1986
The role of pharmacokinetics in risk assessmentR H Reitz, T R Fox, P G Watanabe
Journal De Toxicologie Clinique Et Experimentale|January 1, 1988
Mechanistic considerations in carcinogenic risk estimationP G Watanabe, R H Reitz, A M Schumann
Advances in Experimental Medicine and Biology|January 1, 1981
Translation of pharmacokinetic/biochemical data into risk assessmentF K Dietz, R H Reitz, P G Watanabe, et al.
Food and Cosmetics Toxicology|October 1, 1981
Genetic and nongenetic events in neoplasiaW T Stott, R H Reitz, A M Schumann, et al.
Science (New York, N.Y.)|September 21, 1979
Chemical carcinogens: estimating the riskR H Reitz, J F Quast, P G Watanabe, et al.
Toxicology Letters|October 1, 1988
Pharmacokinetics, biochemical mechanism and mutation accumulation: a comprehensive model of chemical carcinogenesisR B Conolly, R H Reitz, H J Clewell, et al.
Basic Life Sciences|January 1, 1982
Genetic vs. nongenetic chemical carcinogenesis and risk assessmentR H Reitz, A M Schumann, P G Watanabe, et al.
Toxicology and Applied Pharmacology|February 1, 1996
In vivo and in vitro studies of perchloroethylene metabolism for physiologically based pharmacokinetic modeling in rats, mice, and humansR H Reitz, M L Gargas, A L Mendrala, et al.
Toxicology Letters|October 1, 1988
Incorporation of in vitro enzyme data into the physiologically-based pharmacokinetic (PB-PK) model for methylene chloride: implications for risk assessmentR H Reitz, A L Mendrala, C N Park, et al.
Pageof 4